News
KLRA
22.98
+0.17%
0.04
Kailera Therapeutics CEO Ron Renaud presents at Jefferies Global Healthcare Conference
PUBT · 22h ago
Jefferies Sticks to Their Buy Rating for Kailera Therapeutics, Inc. (KLRA)
TipRanks · 1d ago
Analyst Initiates Buy on Kailera, Citing Diversified GLP‑1 Pipeline and Pivotal 2027 Obesity Data Catalysts
TipRanks · 2d ago
TD Cowen Reaffirms Their Buy Rating on Kailera Therapeutics, Inc. (KLRA)
TipRanks · 2d ago
Kailera Therapeutics Q1 EPS $(3.65) Misses $(0.68) Estimate as R&D Spend Jumps to $70.9M
Benzinga · 2d ago
Kailera Therapeutics, Inc. reports Q1 results
Seeking Alpha · 2d ago
Kailera Q1 FY26 net loss more than quadruples to $78.87 million
PUBT · 2d ago
KAILERA THERAPEUTICS INC - Q1 NET LOSS $78.9 MLN
Reuters · 2d ago
KAILERA THERAPEUTICS INC - CASH ON HAND EXPECTED TO FUND OPERATIONS INTO MID-2028
Reuters · 2d ago
KAILERA REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CLINICAL DATA UPDATES
Reuters · 2d ago
*Kailera Therapeutics: Cash on Hand, Including IPO Proceeds, Expected to Fund Ops Into Mid-2028 >KLRA
Dow Jones · 2d ago
*Kailera Therapeutics 1Q Loss $78.9M >KLRA
Dow Jones · 2d ago
Press Release: Kailera Reports First Quarter 2026 -2-
Dow Jones · 2d ago
Press Release: Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
Dow Jones · 2d ago
Weekly Report: what happened at KLRA last week (0518-0522)?
Weekly Report · 4d ago
Kailera Therapeutics, Inc. (KLRA) Receives a Buy from TD Cowen
TipRanks · 05/21 16:55
Weekly Report: what happened at KLRA last week (0511-0515)?
Weekly Report · 05/18 10:52
Analysts Offer Insights on NA Companies: Arxis, Inc. Class A (ARXS) and Kailera Therapeutics, Inc. (KLRA)
TipRanks · 05/17 16:41
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
The Motley Fool · 05/16 14:50
KAILERA THERAPEUTICS INC <KLRA.O>: TD COWEN INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $57
Reuters · 05/14 05:08
More
Webull provides a variety of real-time KLRA stock news. You can receive the latest news about Kailera Therapeutics through multiple platforms. This information may help you make smarter investment decisions.
About KLRA
Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.